Fusion Pharmaceuticals Inc (FUSN)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track

Stock chart

Ticker: FUSN Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Earnings

Value bought

Past 90 days

Value sold

Past 90 days

Net insiders buying

Past 90 days

Trades (buy and sell)

Past 90 days

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2024-06-05	2024-06-04	S Sale	O'Leary, James John Senior Officer of Issuer Officer	300 21.00 USD 6,300	300	21.00	USD 6,300
2024-06-05	2024-06-04	S Sale	Crowley, John Joseph Senior Officer of Issuer Officer	6,500 21.00 USD 136,500	6,500	21.00	USD 136,500
2022-08-11	2022-08-11	B Purchase	GANNON STEVEN Non-Executive Director	44,400 +370.0% 2.03 USD 90,132	44,400 +370.0%	2.03	USD 90,132
2022-04-27	2022-04-27	PS Planned sale	Valliant John Chief Executive Officer Executive Director	4,511 -1.4% 6.03 USD 27,201	4,511 -1.4%	6.03	USD 27,201
2022-04-27	2022-04-26	PS Planned sale	Valliant John Chief Executive Officer Executive Director	2,147 -0.7% 6.07 USD 13,032	2,147 -0.7%	6.07	USD 13,032
2022-04-27	2022-04-25	PS Planned sale	Valliant John Chief Executive Officer Executive Director	2,036 -0.6% 6.03 USD 12,277	2,036 -0.6%	6.03	USD 12,277
2022-04-22	2022-04-21	PS Planned sale	Valliant John Chief Executive Officer Executive Director	922 -0.3% 6.01 USD 5,541	922 -0.3%	6.01	USD 5,541
2022-04-22	2022-04-20	PS Planned sale	Valliant John Chief Executive Officer Executive Director	367 -0.1% 6.02 USD 2,209	367 -0.1%	6.02	USD 2,209
2022-04-13	2022-04-13	PS Planned sale	Valliant John Chief Executive Officer Executive Director	11,994 -3.5% 6.41 USD 76,882	11,994 -3.5%	6.41	USD 76,882
2022-04-13	2022-04-12	PS Planned sale	Valliant John Chief Executive Officer Executive Director	18,255 -5.1% 7.10 USD 129,611	18,255 -5.1%	7.10	USD 129,611
2022-04-13	2022-04-11	PS Planned sale	Valliant John Chief Executive Officer Executive Director	2,600 -0.7% 7.37 USD 19,162	2,600 -0.7%	7.37	USD 19,162
2022-04-08	2022-04-08	PS Planned sale	Valliant John Chief Executive Officer Executive Director	826 -0.2% 7.52 USD 6,212	826 -0.2%	7.52	USD 6,212
2022-04-08	2022-04-07	PS Planned sale	Valliant John Chief Executive Officer Executive Director	1,255 -0.3% 7.56 USD 9,488	1,255 -0.3%	7.56	USD 9,488
2022-04-08	2022-04-06	PS Planned sale	Valliant John Chief Executive Officer Executive Director	100 -0.0% 7.58 USD 758	100 -0.0%	7.58	USD 758
2022-04-05	2022-04-05	PS Planned sale	Valliant John Chief Executive Officer Executive Director	2,100 -0.6% 7.67 USD 16,107	2,100 -0.6%	7.67	USD 16,107
2022-04-05	2022-04-04	PS Planned sale	Valliant John Chief Executive Officer Executive Director	700 -0.2% 7.81 USD 5,467	700 -0.2%	7.81	USD 5,467
2022-04-05	2022-04-01	PS Planned sale	Valliant John Chief Executive Officer Executive Director	1,000 -0.3% 7.75 USD 7,750	1,000 -0.3%	7.75	USD 7,750
2022-04-01	2022-03-30	PS Planned sale	Valliant John Chief Executive Officer Executive Director	300 -0.1% 7.52 USD 2,256	300 -0.1%	7.52	USD 2,256
2022-03-29	2022-03-29	PS Planned sale	Valliant John Chief Executive Officer Executive Director	200 -0.1% 7.52 USD 1,504	200 -0.1%	7.52	USD 1,504
2022-03-29	2022-03-28	PS Planned sale	Valliant John Chief Executive Officer Executive Director	9,600 -2.5% 7.55 USD 72,480	9,600 -2.5%	7.55	USD 72,480
2022-03-29	2022-03-25	PS Planned sale	Valliant John Chief Executive Officer Executive Director	500 -0.1% 7.42 USD 3,710	500 -0.1%	7.42	USD 3,710
2022-03-24	2022-03-23	PS Planned sale	Valliant John Chief Executive Officer Executive Director	100 -0.0% 7.50 USD 750	100 -0.0%	7.50	USD 750
2022-03-24	2022-03-22	PS Planned sale	Valliant John Chief Executive Officer Executive Director	4,000 -1.0% 7.53 USD 30,120	4,000 -1.0%	7.53	USD 30,120
2022-03-24	2022-03-21	PS Planned sale	Valliant John Chief Executive Officer Executive Director	700 -0.2% 7.46 USD 5,222	700 -0.2%	7.46	USD 5,222
2022-03-21	2022-03-21	PS Planned sale	Valliant John Chief Executive Officer Executive Director	1,500 -0.4% 7.47 USD 11,205	1,500 -0.4%	7.47	USD 11,205
2022-03-21	2022-03-18	PS Planned sale	Valliant John Chief Executive Officer Executive Director	1,204 -0.3% 7.61 USD 9,162	1,204 -0.3%	7.61	USD 9,162
2022-03-21	2022-03-17	PS Planned sale	Valliant John Chief Executive Officer Executive Director	900 -0.2% 7.51 USD 6,759	900 -0.2%	7.51	USD 6,759
2022-03-16	2022-03-16	PS Planned sale	Valliant John Chief Executive Officer Executive Director	100 -0.0% 6.99 USD 699	100 -0.0%	6.99	USD 699
2022-03-16	2022-03-15	PS Planned sale	Valliant John Chief Executive Officer Executive Director	100 -0.0% 7.12 USD 712	100 -0.0%	7.12	USD 712
2022-03-16	2022-03-14	PS Planned sale	Valliant John Chief Executive Officer Executive Director	1,300 -0.3% 6.96 USD 9,048	1,300 -0.3%	6.96	USD 9,048
2022-03-14	2022-03-11	PS Planned sale	Valliant John Chief Executive Officer Executive Director	100 -0.0% 7.13 USD 713	100 -0.0%	7.13	USD 713
2022-03-14	2022-03-10	PS Planned sale	Valliant John Chief Executive Officer Executive Director	1,900 -0.5% 7.06 USD 13,414	1,900 -0.5%	7.06	USD 13,414
2022-03-14	2022-03-09	PS Planned sale	Valliant John Chief Executive Officer Executive Director	822 -0.2% 6.94 USD 5,705	822 -0.2%	6.94	USD 5,705
2022-03-08	2022-03-08	PS Planned sale	Valliant John Chief Executive Officer Executive Director	3,004 -0.8% 6.92 USD 20,788	3,004 -0.8%	6.92	USD 20,788
2022-03-08	2022-03-07	PS Planned sale	Valliant John Chief Executive Officer Executive Director	3,100 -0.8% 6.99 USD 21,669	3,100 -0.8%	6.99	USD 21,669
2022-03-08	2022-03-04	PS Planned sale	Valliant John Chief Executive Officer Executive Director	8,400 -2.1% 7.32 USD 61,488	8,400 -2.1%	7.32	USD 61,488
2022-03-03	2022-03-03	PS Planned sale	Valliant John Chief Executive Officer Executive Director	200 -0.0% 7.28 USD 1,456	200 -0.0%	7.28	USD 1,456
2022-03-03	2022-03-02	PS Planned sale	Valliant John Chief Executive Officer Executive Director	26,546 -6.2% 7.44 USD 197,502	26,546 -6.2%	7.44	USD 197,502
2022-03-03	2022-03-01	PS Planned sale	Valliant John Chief Executive Officer Executive Director	847 -0.2% 7.37 USD 6,242	847 -0.2%	7.37	USD 6,242
2022-02-28	2022-02-28	PS Planned sale	Valliant John Chief Executive Officer Executive Director	3,100 -0.7% 7.40 USD 22,940	3,100 -0.7%	7.40	USD 22,940
2022-02-28	2022-02-25	PS Planned sale	Valliant John Chief Executive Officer Executive Director	8,152 -1.8% 7.57 USD 61,711	8,152 -1.8%	7.57	USD 61,711
2022-02-28	2022-02-24	PS Planned sale	Valliant John Chief Executive Officer Executive Director	2,500 -0.6% 7.41 USD 18,525	2,500 -0.6%	7.41	USD 18,525
2022-02-23	2022-02-23	PS Planned sale	Valliant John Chief Executive Officer Executive Director	29,299 -6.2% 7.77 USD 227,653	29,299 -6.2%	7.77	USD 227,653
2022-02-23	2022-02-22	PS Planned sale	Valliant John Chief Executive Officer Executive Director	4,100 -0.9% 7.85 USD 32,185	4,100 -0.9%	7.85	USD 32,185
2022-02-23	2022-02-18	PS Planned sale	Valliant John Chief Executive Officer Executive Director	4,898 -1.0% 7.88 USD 38,596	4,898 -1.0%	7.88	USD 38,596
2022-02-17	2022-02-17	PS Planned sale	Valliant John Chief Executive Officer Executive Director	1,700 -0.3% 7.98 USD 13,566	1,700 -0.3%	7.98	USD 13,566
2022-02-17	2022-02-16	PS Planned sale	Valliant John Chief Executive Officer Executive Director	33,202 -6.4% 7.99 USD 265,284	33,202 -6.4%	7.99	USD 265,284
2022-02-17	2022-02-15	PS Planned sale	Valliant John Chief Executive Officer Executive Director	12,600 -2.4% 8.33 USD 104,958	12,600 -2.4%	8.33	USD 104,958
2021-08-20	2021-08-19	B Purchase	GANNON STEVEN Non-Executive Director	3,000 +48.6% 8.05 USD 24,150	3,000 +48.6%	8.05	USD 24,150
2021-08-20	2021-08-18	B Purchase	GANNON STEVEN Non-Executive Director	171 +2.9% 8.05 USD 1,377	171 +2.9%	8.05	USD 1,377
2020-12-29	2020-12-24	S Sale	ADAMS STREET PARTNERS LLC Large shareholder	1,584 -0.1% 12.32 USD 19,515	1,584 -0.1%	12.32	USD 19,515
2020-12-29	2020-12-24	S Sale	ADAMS STREET PARTNERS LLC Large shareholder	681 -0.1% 12.32 USD 8,390	681 -0.1%	12.32	USD 8,390
2020-12-29	2020-12-24	S Sale	ADAMS STREET PARTNERS LLC Large shareholder	455 -0.1% 12.32 USD 5,606	455 -0.1%	12.32	USD 5,606
2020-12-29	2020-12-24	S Sale	ADAMS STREET PARTNERS LLC Large shareholder	469 -0.1% 12.32 USD 5,778	469 -0.1%	12.32	USD 5,778
2020-12-29	2020-12-24	S Sale	ADAMS STREET PARTNERS LLC Large shareholder	611 -0.1% 12.32 USD 7,528	611 -0.1%	12.32	USD 7,528
2020-12-28	2020-12-23	S Sale	ADAMS STREET PARTNERS LLC Large shareholder	1,905 -0.1% 12.39 USD 23,603	1,905 -0.1%	12.39	USD 23,603
2020-12-28	2020-12-23	S Sale	ADAMS STREET PARTNERS LLC Large shareholder	819 -0.1% 12.39 USD 10,147	819 -0.1%	12.39	USD 10,147
2020-12-28	2020-12-23	S Sale	ADAMS STREET PARTNERS LLC Large shareholder	547 -0.1% 12.39 USD 6,777	547 -0.1%	12.39	USD 6,777
2020-12-28	2020-12-23	S Sale	ADAMS STREET PARTNERS LLC Large shareholder	564 -0.1% 12.39 USD 6,988	564 -0.1%	12.39	USD 6,988
2020-12-28	2020-12-23	S Sale	ADAMS STREET PARTNERS LLC Large shareholder	734 -0.1% 12.39 USD 9,094	734 -0.1%	12.39	USD 9,094
2020-07-02	2020-06-30	B Purchase	TPG Group Holdings (SBS) Advisors, Inc.	250,000 +10.9% 17.00 USD 4,250,000	250,000 +10.9%	17.00	USD 4,250,000
2020-07-02	2020-06-30	B Purchase	Khuong Chau Quang Non-Executive Director	192,100 +inf% 17.00 USD 3,265,700	192,100 +inf%	17.00	USD 3,265,700
2020-07-02	2020-06-30	B Purchase	Khuong Chau Quang Non-Executive Director	705,900 +31.7% 17.00 USD 12,000,300	705,900 +31.7%	17.00	USD 12,000,300
2020-07-02	2020-06-30	B Purchase	Christenson Johan Non-Executive Director	240,000 +6.7% 17.00 USD 4,080,000	240,000 +6.7%	17.00	USD 4,080,000
2020-07-02	2020-06-30	B Purchase	ORBIMED ADVISORS LLC Non-Executive Director	192,100 +inf% 17.00 USD 3,265,700	192,100 +inf%	17.00	USD 3,265,700
2020-07-02	2020-06-30	B Purchase	ORBIMED ADVISORS LLC Non-Executive Director	705,900 +31.7% 17.00 USD 12,000,300	705,900 +31.7%	17.00	USD 12,000,300
2020-07-02	2020-06-30	B Purchase	JOHNSON & JOHNSON Large shareholder	725,000 +24.6% 17.00 USD 12,325,000	725,000 +24.6%	17.00	USD 12,325,000
2020-07-02	2020-06-30	B Purchase	HealthCap VII, L.P. Large shareholder	240,000 +6.7% 17.00 USD 4,080,000	240,000 +6.7%	17.00	USD 4,080,000
2020-07-02	2020-06-30	B Purchase	O'Leary James J Chief Medical Officer Officer	300 +inf% 17.00 USD 5,100	300 +inf%	17.00	USD 5,100
2020-07-02	2020-06-30	B Purchase	Preston Heather Non-Executive Director	8,823 +inf% 17.00 USD 149,991	8,823 +inf%	17.00	USD 149,991
2020-07-02	2020-06-30	B Purchase	Crowley John J Chief Financial Officer Officer	6,500 +inf% 17.00 USD 110,500	6,500 +inf%	17.00	USD 110,500

Fusion Pharmaceuticals Inc (FUSN)

Track

Stock chart

Earnings

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Insider

Sort by